US3576823A - Substituted derivative of 3alpha,12beta-dihydro-8h- -dibenzo(3,4:6,7)cyclohepta(1,2-d)-1,3-dioxole - Google Patents

Abstract

THE PRESENT INVENTION RELATES TO DERIVATIVES OF DIBENZOCYCLOHEPTENES USEFUL BECAUSE OF THEIR ANTIDEPRESSANT ACTIVITY. THE INVENTION INCLUDES THESE COMPOUNDS AS WELL AS PROCESSES AND INTERMEDIATES USEFUL IN THEIR PREPARATION. THESE COMPOUNDS ARE PREPARED FROM THE KNOWN 3A,12B - DIHYDRO-2,2-DIMETHYL-5H-DIBENZO(O,4:6,7)CYCLOHEPTA(1,2-D) - 1,3-DIOXOL-8-ONE AND DERIVATIVES THEREOF WHICH CONTAIN ADDITIONAL SUBSTITUENTS IN ANY POSITION OF THE BENZENOID RING. THIS STARTING MATERIAL, ALTERNATVELY KNOWN AS THE ACETONIDE OF 10,11-DIHYDROXY10,11-DIHYDRO-5H-DIBENZO-(A,D)CYCLOHEPTEN-5-ONE IS CONVERTED BY TREATMENT WITH A 3 - DIALKYLAMINOPROPYLIDENE MAGNESIUM HALIDE TO PRODUCE THE CORRESPONDING 5-HYDROXY -5 - (3DIALKYLAMINOPROPYLIDENE) COMPOUND WHICH IS THEN DEHYDRATED UNDER ACIDIC CONDITIONS TO PRODUCE THE ACETONIDE OF 10,11-DIHYDROXY-10,11-DIHYDRO-5(3-DIALKYLAMINOPROPYLIDENE) - 5H-DIBENZO(A,D)CYCLOHEPTENE. THIS PRODUCT IS HYDROLYZED TO PRODUCE THE CORRESPONDING 10,11 - DIHYDROXY - 5-(3-ALKYLAMINOPROPYLIDENE)-5H-DIBENZO(A,D)CYCLOHEPTENE.

Description

United States Patent O ice Int. Cl. C07d 13/08 US. Cl. 260340.5 4 Claims ABSTRACT OF THE DISCLOSURE The present invention relates to derivatives of dibenzocycloheptenes useful because of their antidepressant activity. The invention includes these compounds as well as processes and intermediates useful in their preparation. These compounds are prepared from the known 311,123 dihydro-2,2-dimethyl-SH-dibenzo[3,4 6,7] cyclohepta[1,2-d) 1,3-diXol-8-one and derivatives thereof which contain additional substituents substituted in any position of the benzenoid ring. This starting material, alternatvely known as the acetonide of 10,1l-dihydr0Xy- 10,1l-dihydro-SH-dibenzo-[a,d] cyclohepten-S-one is converted by treatment with a 3 dialkylaminopropylidene magnesium halide to produce the corresponding -hydroxy -5 (3-dialkylaminopropylidene) compound which is then dehydrated under acidic conditions to produce the acetonide of 10,l1-dihydroxy-1O,11-dihydro 5(3-dialkylaminopropylidene) 5H-dibenzo[a,d]cycloheptene. This product is hydrolyzed to produce the corresponding 10,11 dihydroxy 5-(3-alkylaminopropylidene)-5H-dibenzo[a,d]cycloheptene.

This is a division of application Ser. No, 296,463, filed July 22, 1963 now US. Pat. No. 3,390,179.

This invention relates to derivatives of dibenzocycloheptenes. In particular, the invention relates to 10,11-dihydro 10,11 dihydroxy-S-(3-substituted aminopropylidene)-5H-dibenzo[a,d]cycloheptenes and methods of preparing the same. The invention also relates to intermediates useful in the preparation of the above compounds, as well as processes for the preparation of said intermediates.

The end compounds embraced within the scope of the present invention may be represented by the following structural formulae:

Ho on Ho 0 8 9 10 11 X' I '-X' and X X CHCHzCHzN\ HCH CH NHR I R II wherein R is a lower alkyl radical, straight or branched chain, preferably having up to 6 carbon atoms; R is a lower alkyl radical, straight or branched chain, preferably having up to 6 carbon atoms and X and X, which may be similar or dissimilar, are hydrogen, an alkyl group having up to 6 carbon atoms, an alkenyl group having up to 6 carbon atoms, halogen, trifluoromethyl, hydroxyl,

3,576,823 Patented Apr. 27, 1971 an alkoxy group having up to 4 carbon atoms, mercapto, an alkylmercapto group having up to 4 carbon atoms, an alkylsulfonyl group having up to 4 carbon atoms, sulfamoyl, an alkylsulfamoyl group having up to 4 carbon atoms or a dialkylsulfamoyl group having up to 8 carbon atoms. More than one of these substituents may be on each of the benzenoid rings.

The compounds represented by the above structural formulae may also have substituents on the propylidene side chain such as lower alkyl radicals, preferably having from 1 to 4 carbon atoms.

Representative end compounds encompassed Within the scope of the present invention include:

10,1 1-dihydro-10,ll-dihydroxy-5-[3-(1-piperidyl)- propylidene] -5H-dibenzo [a,d] cycloheptene 10,1 1-dihydro-10,1 1-dihydroXy-5-[3-(1-methyl-4- piperazinyl) propylidene] -5H-dibenzo [a,d] cycloheptene 10,1 l-dihydro-IO,1l-dihydroxy-S-(3-dimethylaminopropylidene -5H-dibenzo a,d] cycloheptene 10,11-dihydro-10,1l-dihydroxy-S-(3-methylaminopropylidene -5H-dibenzo [a,d] cycloheptene 3-chloro-10,11-dihydro-10,1 l-dihydroxy-S- 3-dimethy1- aminopropylidene -5H-dibenzo [a,d] cycloheptene 10,11-dihydro-10,1 l-dihydroxy-S- 3-methylaminopropylidene -3-methylsulfony1-SH-dibenzo [a,d] cycloheptene 10,1l-dihydro-10,1l-dihydroxy-S-(3-dimethylaminopropylidene) 3-trifluoromethyl-SH-dibenzo [a,d] cycloheptene 10,1 1-dihydro-10,1 l-dihydroxy-S- 3-diethylaminopro pylidene -3 -dimethylsulfamoyl-SH-dib enzo- [a,d] cycloheptene The compounds represented by the above structural formulae can advantageously be employed in pharmaceutical applications because they have been found to possess anti-depressant activity. As anti-depressants, they may be administered orally in the form of tablets, powders, sustained release pellets and the like, or they may be administered orally or parenterally in the form of aqueous solutions or suspensions. When administered orally or parenterally, satisfactory results are obtained at a daily dosage level of from about 60 mg. to about 1,000 mg, preferably given in divided doses over the day or in sustained release form. The compounds are preferably administered in the form of their non-toxic acid addition salts and these salts are included within the scope of this invention.

The compounds represented by the above structural formulae exist as geometric isomers, which are determined by the steric relationships of the hydroxyl groups to each other. In order to prepare the separate isomers, it is necessary to employ an appropriate starting material in the same isomeric form as that desired of the end product. Thus, where it is desired to prepare the trans isomer of the compounds represented structurally above, a trans 30:,125 dihydro-8H-dibenzo[3,4:6,7]cyclohepta- [1,2-d]-1,3-dioxol-8-one is employed, whereas the cis isomers are prepared starting with a cis 10,11-dihydro- 10,1 l-diacyloxy-SH-dibenzo a,d] cyclohepten-S-one.

In carrying out the process, the desired ketone is treated with a Grignard reagent, namely, a tertiary aminopropylmagnesium halide and the Grignard adduct obtained hydrolyzed to form the corresponding 5-hydroxy-5-(3-tertiary aminopropyl) derivative. This is then dehydrated to form the corresponding 5-(3-tertiary aminopropylidene) derivative, which is then either hydrolyzed to form the cis or trans 10,11-dihydroxy compounds represented by structural Formula I or dealkylated and then hydrolyzed to form the cis or trans 10,11-dihydroxy compounds represented by structural Formula II.

The process for the preparation of the trans 10,11-dihydroxy compounds represented by structural Formula I may be illustrated as follows:

R 1. HEIMECHQCHZCEHN Hydrolysis Step A C O O H /R H CH2CHzCHgN Dehydration Step B RI! R!!! Hydrolysis Step 0 /R HCHzCHzN HO OH R CHCH2CH2N wherein Hal represents halogen, preferably chlorine or bromine and X, X, R and R are as previously defined; and R" and R are hydrogen, alkyl, aralkyl or aryl.

The starting compound, wherein X and X are both hydrogen and R" and R are both methyl, namely, the 30, 12;? dihydro-2,Z-dimethyl-SH-dibenzo[3,4:6,7]cyclohepta[1,2-d]-1,3-dioxol-8-one, may be prepared in the manner described by G. L. Buchanan and D. B. Jhaveri in the J. Org. Chem. 26, 4295-4299 (1961). Those starting compounds, wherein at least one of X and X is other than hydrogen, may be prepared from the corresponding nuclearly substituted SH-dibenzo[a,d]cyclohepten--one utilizing the procedure of G. L. Buchanan and D. B. Jhaveri, referred to above. The latter compounds may be prepared following the teachings of T. W. Campbell et al. in an article appearing in Helv. Chem. Acta, vol. 36, pages 1489- 1499 (1953).

Those starting compounds, wherein R and R" are other than methyl, may be prepared from the corresponding diol by treatment with an appropriate aldehyde or ketone utilizing the procedure described by G. L. Buchanan and D. B. Jhaveri for the preparation of the acetonide of the trans diol appearing in the article referred to above.

It should be noted that inasmuch as the R" and R' substituents are removed during the preparation of the end compounds of this invention, the selection of the particular starting compound with respect to these substituents will be dependent only upon their case of preparation and the removal of the R and R' substituents during subsequent hydrolysis.

The Grignard reagent employed in Step A of the above process may be prepared by known procedures, but it has been found that it may be prepared in high yields as follows:

HalMgCHZCH CH N It has been found that the use of tetrahydrofuran as the solvent for the reaction results in a rapid production of the Grignard reagent in high yield.

The reaction with the Grignard reagent (Step A) is preferably initially carried out under cooled conditions such as by the use of an ice-bath, and finally may continue at room temperature. It has been found that tetrahydrofuran is a suitable solvent for carrying out the reaction and, accordingly, the ketone may be added directly to the reaction mixture in which the Grignard reagent was prepared. However, any inert solvent for the reactants may be employed.

After the addition reaction is completed, the bulk of the solvent is removed by vacuum distillation, the Grignard adduct dissolved in a suitable solvent such as benzene, and hydrolyzed by the addition of water or ammonium chloride solution with cooling. The product is recovered by evaporation of the solvent after the removal of any residual inorganic material by filtration.

Conversion of the carbinol to the corresponding 5-(3- tertiary aminopropylidene) derivative (Step B) is effected by dehydration. The dehydration may be effected in conventional manner employing such commonly used dehydrating agents as acetyl chloride, acetic anhydride or thionyl chloride. The alcohol may be dehydrated directly or may be first converted to a salt such as the hydrochloride, hydrobromide or sulfate. Conversion to the salt prior to dehydration may be preferable in some cases. The reaction may be carried out at elevated temperatures, and in an excess of dehydrating agent or a solvent such as chloroform or glacial acetic acid may be employed. The desired product is recovered after rendering the mixture alkaline by extraction with a suitable solvent, and then removing the solvent.

Conversion of the compound obtained from Step B to the corresponding trans 10,11-dihydroxy compound (Step C) is eifected by hydrolyzing the former in an inert solvent, preferably at elevated temperatures, and in the presence of an acidic catalyst such, as for example, p-toluenesulfonic acid, concentrated sulfuric acid, trifluoroacetic acid, dry hydrochloric acid and the like. Any number of inert solvents may be utilized, but it is preferred to employ a lower alkanol such as methanol, ethanol, isopropanol and the like. Where the product is insoluble in the solvent employed, it may be recovered by filtration and washed free of any residual acid and further purified by conventional methods. Where the product is soluble in the solvent employed, it may be recovered by evaporation of the solvent, diluting with water, neutralizing any residual acid with sufficient alkali to render the medium basic and collecting the residue by conventional methods.

The trans 10,11-dihydroxy compounds represented by structural Formula 11 may be prepared from the corresponding 5-(3-dialkylaminopropylidene) compound obtained in Step B above. In carrying out the process, it is preferred that the alkyl substituents attached to the nitrogen atom be the same. This is readily accomplished by appropriate selection of the Grignard reagent used to prepare the carbinol from which the tertiary aminopropylidene compound is derived. This process may be illustrated as follows:

/ Haloforrnate Hal COOR X X Step D CHOH2CH2N(R)2 RI! R!!! i l Kg CHCHzCHzNHR wherein Hal, X, X, R, R" and R are as previously defined and R"" is alkyl, aralkyl and aryl. However, it will be readily appreciated by those skilled in the art that inasmuch as the R" substituent is removed during the dealkylation step, the selection of the particular haloformate will be limited only by its availability and subsequent ease of hydrolysis of the intermediate urethane produced.

Step D of the above process involves the condensation of the tertiary amino compound with a haloformate to form the corresponding urethane intermediate. While the reaction can be carried out in the absence of a solvent, it is preferable to employ a solvent. Suitable solvents include the aomatic hydocabons such as benzene and toluene, aliphatic hydocarbons such as heptane and hexane, and the halogen hydrocarbons such as chloroform and carbon tetrachloride. The reaction may be carried out at room temperature, although an elevated temperature is preferred. At the conclusion of the reaction, the urethane is recovered, after removal of impurities, by evaporation of the solvent.

The urethane intermediate thus produced is then subjected to hydrolysis (Step E). The hydrolysis preferably may be carried out under basic conditions. After completion of the hydrolysis, the desired product is recovered in conventional manner, such as by extraction into a suitable solvent and evaporation of the solvent. Conversion to the corresponding 10,11-dihydroxy compound is accomplished using the procedure outlined in Step C.

Alternatively, the dealkylation may be accomplished by treatment of the tertiary aminopropylidene compound with a cyanogen halide to form the corresponding cyanamide intermediate, and the cyanamide thus produced hydroylzed to the corresponding secondary amine. This process may be illustrated as follows:

Hal- CN Hydrolysis R CHCH2CH N Step 0 CHCHzCHzNHR HO OH The tertiary amine is dissolved in a nonhydroxylic solvent such as benzene or ether and the solution slowly added to a solution of cyanogen halide in the same solvent, While stirring and permitting the alkyl halide to escape. After the reaction is complete, the basic material is separated by washing with dilute acid and the cyanamide isolated by evaporating the solvent. The cyanamide is hydrolyzed to the secondary amine in an alkaline medium, and the product recovered in conventional manner. Conversion to the corresponding 10,11-dihydroxy compound is accomplished using the procedure outlined in Step C.

The 5 (3 tertiary aminopropylidene) 5H dibenzo [a,d]cycloheptene employed in the process may be readily obtained by treating the appropriately substituted 5H- dibenzo[a,d]cyclohepten 5 one with a Grignard reagent, namely, tertiary aminopropyl magnesium halide, hydrolyzing the resulting Grignard adduct to form the corresponding carbinol and dehydrating the latter, as de scribed in the literature.

The preparation of the cis 10,11-dihydroxy compounds represented by structural Formula II may be accomplished by dealkylating the corresponding cis 10,11 diacyloxy- 5 (3 dialkylaminopropylidene) derivative in the same manner as described for the dealkylation of the trans 5 (3 dialkylaminopropylidene) derivative, as described 7 in Steps D and E above. This process may be illustrated as follows:

/ Haloformate HalC O O R" x X Step D CHCH2CH2N(R)2 GHCH2OH N Hydrolysis Stop E HO OH \CQHZOHZNHR wherein Ac, Hal, R, R"", X and X are as previously defined.

It should be noted that the alternate method of dealkylation mentioned hereinabove for the preparation of the trans 10,11-dihydroxy compounds of structural Formula II cannot be used for the preparation of the cis 10,11-dihydr0xy compounds of Formula II.

It will be readily appreciated by those skilled in the art that the compounds represented by structures I and II, in addition to the element of geometric isomerism determined by the relationship of the hydroxyls to each other, possess a second element of geometric isomerism when the dibenzocycloheptene nucleus is unsymmetrically substituted, depending on the position of the propylidene side chain relative to the nuclear substituent(s).

The separation of these isomers can be achieved by conventional techniques. While the mixture of such isomers possess pharmacological activity, in some instances the activity may be greater in one pure isomer than the other.

Inasmuch as the compounds of this invention may exist an geometric isomers with respect to the hydroxyl substituents only or with respect to both the hydroxyl substituents and the propylidene side chain, the following procedure for designating the isomers hereinabove and in the examples and claims which follow has been employed. Where isomers exist only with respect to the hydroxyl substituents, the designation of the particular isomer precedes the name of the compound. Where isomers exist as to both the hydroxyl substituents and the propylidene side chain, the designation of the isomers immediately precedes the substituent to which it refers. In those instances where isomers exist with respect to both the hydroxyl substituents and the propylidene side chain and the isomers of the latter have not been separated, then only the designation of the isomer with respect to the hydroxyl substituents is given and such designation precedes the name of the compound. However, where no designation of isomers is specified with respect to the compounds of this invention, it is to be understood that all possible stereoisomers are included.

The preparation of representative compounds encompassed within the scope of the present invention is described in the following examples which are illustrative only and are not to be construed as in any way limiting the scope of the invention.

8 EXAMPLE 1 Trans 3a,l2,8-dihydro-2,2-dimethyl 8-(3-dimethylaminopropyl) -8-hydroxy-8H dibenzo 3,4 6,7] cyclohepta l, 2-d]-1,3-dioxole 3-dirnethylarninopropylmagnesium chloride is prepared from magnesium turnings (4.05 g., 0.166 g. atom) and 3-dimethylaminopropyl chloride (20.2 g., 0.166 mole) in 150 ml. of dry tetrahydrofuran, following the method of US. Pat. No. 3,046,283. In a nitrogen atmosphere, a

solution of trans 3a,12 3-dihydro-2,2-dimethyl-SH-dibenzo [3,4:6,7]cyclohepta[1,2 d]-1,3-dioxol-8-one (23.2 g.,

0.083 mole) in ml. of dry tetrahydrofuran is added dropwise to the stirred solution of the Grignard reagent while cooling in an ice-bath. The mixture is allowed to come to room temperature and stirred for 2 hours. The

bulk of the solvent then is distilled below 50 C. under reduced pressure. The residue is dissolved in ml. of

benzene and water, 20 ml., is added dropwise with stirring and cooling. The benzene layer is decanted from the gelatinous precipitate which then is extracted with four 100 ml. portions of boiling benzene. The combined benzene extracts are washed with water and extracted with three 100 ml. portions of 0.5 M citric acid. The acid extract is made basic with sodium hydroxide, and the oily base that separates is extracted into benzene. After washing the combined extracts with water and drying over anhydrous sodium sulfate, the benzene is evaporated and the product obtained as a viscous yellow oil in a yield of 29.5 g. (96%).

The base may be converted to the hydrogen oxalate salt by treating an ethereal solution with a solution of oxalic acid (10% excess) in isopropyl alcohol. The trans 3a,12;3-dihydro-2,2 dimethyl-S (3-dimethylaminopropyl)-8hydroxy-8H dibenzo[3,4:6,7]cyclohepta[1,2-d]- 1,3-dioxole hydrogen oxalate is obtained as a white crystalline solid, M.P. l69--172 C., dec. Repeated recrystallizations from mixtures of isopropyl alcohol and absolute ether give the product, M.P. 171173 C., dec.

Analysis.-Calcd for C H NO -C H O (percent): C, 65.62; H, 6.83. Found (percent): C, 65.08; H, 6.72.

EXAMPLE 2 Product Gn'gnard reagent 3-diethylaminopropylmagnesium chloride.

B-(l-pyrrolidyD-propylmagnesium chloride 3-(l-piperidyl)propylmagnesium chloride.

3-(1-ethyl-4-piperazinyl)-propylmagnesium chlond dibenzo-[3,4:6,7]cyclohepta[1,2-d]-1,3-dioxole. 3-(4-morphoh nyl)-protrans 3a,IZB-dihydro-Z,Z-dimethyl-S-hydroxypylmagnesium 8-[3-(4-morpholinyl)-propyl]-8H-dibenzo 3-(Nethyl-N-methylamino)-propyhnagnesium chloride.

EXAMPLE 3 Following the procedure of Example 1, the products enumerated below are obtained using the Grignard reagent of Example 1 and the ketone designated below.

Ketone Product TABLE-Continued Product Ketone EXAMPLE 4 A solution of trans 3a,l2fl-dihydro-2,2dimethyl-8-(3- dimethylaminopropyl) 8 hydroxy 8H dibenzo- [3,4:6,7]cyclohepta[l,2-d]-1,3-dioxole (1.3 g., 0.00354 mole) in ml. of acetic anhydride is heated to refluxing for 4 hours. The solution is evaporated to dryness under reduced pressure and the residual syrup dissolved in 30 ml. of water. After one extraction with hexane, the aqueous layer is rendered alkaline with sodium hydroxide and the oily base extracted into benzene. The Washed benzene extract is evaporated under reduced pressure, leaving the product as an oily residue weighing, typically, 950- mg. Treatment of an ethereal solution of the base with a solution of 300 mg. of oxalic acid in 3 ml. of isopropyl alcohol precipitates trans 3a,l2;3-dihydro-2,2-dimethyl-8- (3-dimethylamin0propylidene) 8H dibenzo[3,4:6,7]- cyclohepta[l,2-d]-l,3-dioxole hydrogen oxalate, M.P. 204206 C., dec., in a yield of 1.05 g. (67.5%). The pure product from another experiment melts at 205206 C., dec., after recrystallization from isopropyl alcohol.

Analysis.Calcd for C H NO -C H O (percent): C, 68.32; H, 6.65; N, 3.19. Found (percent): C, 68.36; H, 6.72; N, 3.15.

EXAMPLE 5 Following the procedure of Example 4, the products enumerated below are obtained employing the products enumerated in Examples 2 and 3 in place of the dioxole used in Example 4.

trans 8- 3-diethylaminopropylidene) -3 u,12B-dihydro-2,2-

dimethyl- 8H-dibenz0 [3 ,4: 6,7] cyclohepta[ 1,2-d]- 1,3-dioxole trans 3 a,1ZB-dihydro-2,2-dimethyl8-[3-(1-pyrr0lidyl)- propylidene]-8H-dibenzo[3,4: 6,7]cyclohepta[ 1,2-d1- 1 ,3-dioxole trans 3 04,1 ZB-dihydro-2,2-dirnethyl-8- [3- l-piperidyl) propylidene] -8H-dibenzo [3,4 6,7 1 cyclohepta[ 1,2-d] 1,3-dioxole trans 3 a,1ZB-dihydro-2,2-dimethyl-8-[3-(1-ethyl-4-piperiazinyl)-propylidene]-8H-dibenzo[3,426,7]cyc1ohepta[1,2-d]-l,3-diox0le trans 3 a,12B-dihydr0-2,2-dimethyl-8-[3-(4-morpholinyl) propylidene] -8H-dibenzo [3 ,4: 6,7 cyclohepta 1,2-d1- 1,3-di0x0le trans 3 o,lZB-dihydro-2,2-dimethyl-8-[3-(N-etl1yl-N- methylamino) -pr0pylidene] -8Hdibenzo [3 ,4: 6,7] cyclohepta[1,2-d]-1,3-dioxole trans 3 oz, l2fl-dihydro-8- 3-dirnethylaminopropylidene 8H-dibenzo [3,4 6,7] cyclohepta 1,2-d] 1,3-dioxole trans 3a,12,8-dihydro-8-(3-dimethylaminopropylidene)- Z-phenyl-SH-dibenzo 3 ,4: 6,7]cyclohepta[1,2-d]- 1 ,3 -dioxole trans 3 a,12fi-dihydro-8-(3-dimethylaminopropylidene)- Z-methyl-SH-dibenzo [3 ,4: 6,7]cyclohepta[ 1,2-d] 1,3-dioxole trans 2-benzyl-3 a, 12 B-dihydro-S- 3-dimethylaminopropylidene -8H-dibenzo [3,4 6,7] cyclohepta [1,2-d]-1,3-dioxole trans 30c, lZfi-dihydro-S- 3-dimethylaminopropylidene) 2-ethyl-2-methyl-8H-dibenzo [3 ,4: 6,7]cyc1ohepta 1,2-d] -1,3-dioxole trans 3a, l2,8-dihydro-2,2-dimetl1yl-8- (3 -dimethylaminopropylidene) -6-methylsulfonyl-SH-dibenzo [3,4 6,7]- cyclohepta[ 1,2-d] 1,3 -dioxole trans 6-chloro-3 a, 1 Zfi-dihydro-LZ-dimethyl-8- 3 -dimethylaminopropylidene) -8H-dibenzo [3 ,4: 6,7]- cyclohepta[1,2-d] 1,3-dioxole trans 3 a, l 2fi-dihydro-2,2-dimethyl-8( 3-dimethylaminopropylidene -6-dimethylsulfamoyl-8H-dibenzo [3,4 6,7]cyclohepta[ 1,2-d] 1 ,3-dioxole EXAMPLE 6 Trans 10,11 dihydro 10,11 dihydroxy 5 (3 dimethylaminopropylidene) 5H dibenzo[a,d]cycl0- heptene A solution of trans 3a,l2,6-dihydro-2,2-dimethyl-8-(3- dimethylaminopropylidene) 8H dibenzo[3,4:6,7]cyclo hepta[l,2-d]-l,3-dioxole (350 mg., 0.001 mole) and ptoluenesulfonic acid monohydrate (230 mg., 0.0012 mole) in 35 ml. of absolute methanol is heated to refluxing for 4 hours. The cooled solution is neutralized with 1 ml. of l M potassium hydroxide in methanol and then the solvent is distilled under reduced pressure. The residue is partitioned between benzene and water and the aqueous layer re-extracted twice with benzene. The combined benzene extracts are washed with water and then evaporated to dryness under reduced pressure. Trituration of the residue with absolute ether yields the product as a white crystalline solid, M.P. 132.5134.5 C., weighing 230 mg. (74.5%). After purification by sublimation and crystallization from a mixture of ethanol and Water, an analytical sample melts at l34.5-136.5 C.

Analysis.-Calcd for C H NO (percent): C, 77.64; H, 7.49; N, 4.53. Found (percent): C, 77.59; H, 7.42; N, 4.47.

EXAMPLE 7 Following the procedure of Example 6, the products enumerated below are obtained using the products enumerated in Example 5 in place of the dioxole used in Example 6.

trans 5- 3-diethylarninopropylidene) -10,1 l-dihydro- 10,11-dihydroxy-5H-dibenzo[a,d]cycloheptene trans 10,1 1-dihydro-10, l l-dihydroxy-S- [3-( 1-pyrr0-lidyl)- propylidene] -5H-dibenzo [a,d] cycloheptene trans 10,11-dihydro-10,l1-dihydroxy5-[3-(1-piperidyl)- propylidene] -5H-dibenz0 [a,d] cycloheptene trans 10,1 1-dihydro-10,1 1-dihydroxy-5-[3-(1-ethyl-4- piperazinyl) -pr0py1idene] -5H-dibenzo [a,d] cycloheptene trans 10,11-dihydro-10,1l-dihydroxy-S-[3-(4-morpholinyl) propylidene] -5H-dibenzo [a,d] cycloheptene trans 10,11-dihydro-10,1 l-dihydroxy-S- [3- N-ethyl-N- methylamino -propylidene] -5H-dibenz0 [a,d] cycloheptene trans 10,11-dihydro-10,1l-dihydroxy-S-(3-dimethylaminopropylidene -5H-dibenzo a,d] cycloheptene trans 10,1 1-dihydro-10,1 l-dihydroxy-S- 3-dimethylaminopropyliclene) -3 -methylsulfonyl-SI-I-dibenzo [a,d] cycloheptene 1 l trans 3-chloro-10,11-dihydro-10,11-dihydroxy-5-(3- dimethylaminopropylidene) -H-dibenzo [a,d] cycloheptene trans l0,11-dihydro-l0,l l-dihydroxy-S-(B-dimethylaminopropylidene)-3-dimethylsulfamoyl)-5H-dibenzo [a,d] cycloheptene EXAMPLE 8 Trans 8 [3-(N-cyano-N-methylamino)-propylidene] 30:,

12 3 dihydro 2,2-dimethyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-d]-1,3-dioxole In a system protected by a drying tube, and in which a nitrogen atmosphere is maintained, a solution of trans 3u,12fi dihydro-2,2-dimethyl-8-(3-dimethylaminopropylidene) 8H dibenzo[3,4:6,7]cyclohepta[1,2-d]-1,3-dioxole (2.25 g., 0.00645 mole) in 12 ml. of dry benzene is added dropwise over a 30 minute period to a stirred solution (1.85 ml.) of 4.25 M cyanogen bromide in benzene. Stirring is continued for 1 /2 hours and the mixture then allowed to stand at room temperature overnight. Solvent and excess cyanogen bromide are evaporated under reduced pressure and the residue dissolved in benzene. The solution is washed with water, dilute citric acid, then with water, and evaporated to dryness under reduced pressure. The trans 8-[3-(N-cyano-N-methylamino)-propylidene] 3a,l2fi dihydro-2,2-dimethyl-8H-dibenzo[3,4:6, 7]cyclohepta[1,2-d]-1,3-dioxole is obtained as a yellow oily residue, weighing 1.8 g. (78%).

EXAMPLE 9 Following the procedure of Example 8, the products enumerated below are obtained employing the 8-(3-dialkylaminopropylidene) products enumerated in Example 5 in place of the dioxole used in Example 8.

Trans 8- [3-N-cyano-N-methylamino -propylidene] -3 oz,

12,8-dihydro-2,2-dimethyl-8H-dibenzo [3 ,4: 6,7 cyclohepta[1,2-d]-1,3 ,-dioxole Trans 8 3 (N-cyano-N-methylamino -propylidene] 3a,12,8-dihydro-8H-dibenzo [3,4: 6,7] cyclohepta [1,2-d] 1 ,3-dioxole Trans 8- [3 -(N-cyano-N-methylamino) -propylidene] 3 a,12l3-dihydro-2-phenyl-8H-dibenzo[3,4: 6,7]cyclohepta[1,2-d]-1,3-dioxole Trans 8- [3 (N-cyano-N-methylamino) -propylidene] Trans 2-benzyl-8- 3- N-cyano-N-methylamino -propylidene] -3 cc,IZB-CiihYdI'O-EH-dibBHZO[3,426,7]CYC10- hepta[1,2-d]-1,3-dioxole Trans 8- 3- (N-cyano-N-methylamino) -propylidene] 3 oz, 1 ZB-dihydro-2-ethy1-2-methyl-SH-dibenzo [3 ,4: 6,7] cyclohepta[1,2-d]-1,3-dioxole Trans 8- 3 (N-cyano-N-methylamino) -propylidene] 3 cc, 1 2,8-dihydro-2,2-dimethyl-6-methylsulfonyl-8H- dibenzo[3,4:6,7]cyclohepta[1,2-d]-l,3-dioxole Trans 6-chloro-8- 3- (N-cyanoN-methylamino) propylidene] -3a,1Zfl-dihydro-2,2-dimethyl-8H-dibenzo [3 ,4: 6,7]cyclohepta[ 1,2-d]-l1,3 -dioxole Trans 8-[ 3- (N-cyano-N-methylamino) -propylidene] 3 a, l2,8-dihydro-2,2-dimethyl-6-dimethylsulfamoyl-81-1- dibenzo 3 ,4: 6,7] cyclohepta[ 1,2-d]-1,3-dioxole EXAMPLE 10 Trans 3a,12fl dihydro 2,2-dimethyl-8-(3-methylaminopropylidene) 8H-dibenzo[3,4:6,7]cyclohepta[l,2-d]- 1,3-dioxole The oily cyanamide (1.44 g., 0.004 mole), prepared as in Example 8 above, is dissolved in a solution of potassium hydroxide (1.12 g., 0.02 mole) in 12 ml. of n-butyl alcohol and the solution is heated to refluxing in a nitrogen atmosphere for'12 hours. The solvent is distilled under reduced pressure and. the residue partitioned between hexane and water. After two re-extractions of the aqueous layer with hexane, the combined hexane extracts are washed with water and extracted with 50 ml of 0.1 M citric acid. The acid extract is rendered alkaline with sodium hydroxide and the oily base extracted into benzene. The washed and dried benzene extract is evaporated to dryness under reduced pressure, leaving the product as an oily residue weighing, typically, 920 mg.

The base may be converted to the hydrogen oxalate salt by treating an ethanolic solution with a solution of oxalic acid (10% excess) in absolute ethanol. Analytically pure trans 3a,12fl-dihydro-2,2-dimethyl-8-(3-methylaminopropylidene) 8H-dibenzo[3,4:6,7]cyclohepta[1,2-d]- 1,3-dioxole hydrogen oxalate from another experiment melts at 224 C., dec., after repeated recrystallizations from absolute ethanol.

Analysis.Calcd for C H NO -C H O (percent): C, 67.75; H, 6.40; N, 3.29. Found (percent): C, 67.78; H, 6.32; N, 3.41.

Conversion of the oily base (900 mg.) to the p-toluenesulfonate salt by treating an ethereal solution with a solution of p-toluene sulfonic acid monohydrate (5% excess) in absolute ethanol, affords the white crystalline salt, M.P. 148-150 C., dec., in a yield of 950 mg.

EXAMPLE 11 Following the procedure of Example 10, the products enumerated below are obtained employing the products enumerated in Example 9 in place of the cyanamide used in Example 10.

trans 3 a,1ZB-dihydro-2,2-dimethyl-8-(3-ethylaminopropylidene) -8H-dibenzo [3,4: 6,7] cyclohepta[ 1,2-d] 1,3-dioxole trans 3 a,12fi-dihydro-8-(3-methylaminopropylidene)- 8H-dibenzo [3,4 6,7] cyclohepta[ 1,2-d] -1,3-dioxole trans 3 a, 12B-dihydro-8-( 3 -methylaminopropy1idene 2-phenyl-8H-dibenzo [3,4: 6,7] cyclohepa[ 1,2-d1- 1,3-dioxo1e trans 3 a,12fi-dihydro-2-methy1-8-(3-methylaminopropylidene) -8H-dibenzo=[ 3,4: 6,7]cyclohepta[ 1,2-d1- 1,3 -dioxole trans 2-benzyl-3 0c, L2B-dihydro-8- 3-methylaminopropylidene) -8H-dibenzo[3,4: 6,7]'cyclohepta[1,2-d]- 1,3-dioxole trans 3 a,1ZB-dihydro-2-ethyl-2-methyl-8- (3-methylaminopropylidene -8H-dibenzo 3,4: 6,7 cyclohepta [1,2-d] l ,3-diox0le trans 3 a, 1 2 fi-dihydro-2,2-dimethyl-8- (3 -methylaminopropylidene) -6-methylsu1fonyl-8H-dibenzo [3 ,4: 6,7] cyclohepta[1,2-d]-1,3-dioxole trans 6-chloro-3 on, 1 2B-dihydro-2,2-dimethyl-8-( 3- methylaminopropylidene) -8H-dibenzo [3 ,4: 6,7] cyclohepta [1 ,2-d] -1,3-dioxoletrans 3 a,12,8-dihydro-2,2-dimethyl- 6-dimethylsulfa-moyl- 8- 3-methylaminopropylidene) -8H-dibenzo [3 ,4 6,7 1 cyclohepta[1,2-d]-1,3-dioxolel EXAMPLE 12 Trans 10,1 1-dihydro-10,1 l-dihydroxy-S- 3-methylaminopropylidene) -5H-dibenzo [a,d] cycloheptene A solution of trans 3a,12 3-dihydro-2,2-dimethyl-8-(3- methylaminopropylidene) 8H dibenzo[3,4: 6,7]cyclohepta[1,2-d]-1,3-dioxole p-toluene-sulfonate (700 mg, 0.00138 mole) and p-toluenesnlfonic acid monohydrate (60 mg., 0.000316 mole) in '60 ml. of absolute methanol is heated to refluxing for 4 hours. The cooled solution is neutralized with 1.5 ml. of 1 M potassium hydroxide in methanol and then the solvent is distilled under reduced pressure. The residue is partitioned between benzene and water and the aqueous layer re-extracted with benzene. The combined benzene extracts are Washed with Water and then evaporated to dryness under reduced pressure, leaving the product as an oily solid residue. Sublimation of the product at 142 C. and 0.1 mm. aifords white crystals, M.P. 153-155 C., weighing, typically, mg. (30%). An analytical sample is obtained by crystallization from.

Following the procedure of Example 12, the products enumerated below are obtained employing the products enumerated in Example 11 in place of the dioxole used in Example 12.

Trans 10,11-dihydro-l0,1l-dihydroxy-S-(3-ethylaminopropylidene -5H-dibenzo [a,d]cycloheptene Trans 10, 1 1dihydro-10,l 1-dihydroxy-5-(3-methylaminopropylidene) -5H-dibenzo [a,d] cycloheptene Trans 10,1 1-di-hydro-10,1 l-dihydroxy-S- (3-methylamirnopropylidene -3 -methylsulfonyl-SH-dibenzo a,d] cycloheptene Trans 3-chloro-l0,1 1-dihydro-10,1 1-dihydroxy-5-(3- methylaminopropylidene) -5H-dibenzo [a,d] cycloheptene Tra-ns 10,1 1-dihydro-l0, l l-dihydroxy-3 -dimethylsulfamoyl-5 3-methyla1minopropylidene) -5H-dibenzo [a,d] cycloheptene EXAMPLE 14 Cis 5 [3-(N-carbethoxy-N-methylamino)-propylidene]- 10,11 diacetoxy-l0,1l-dihydro-SH-dibenzo[a,d]cycloheptene A solution of cis 10,11-diacetoxy-l0,11-dihydro-5-(3- dimethylarninopropylidene) 5H dibenzo[a,d] cycloheptene (7.86 g., 0.02 mole) in 40 ml. of dry benzene is added dropwise over a 90 minute period to a stirred solution of 8 ml. of ethyl chloroformate in 20 ml. of dry benzene. The mixture then is stirred at reflux for 2 /2 hours. After cooling and diluting with 50' ml. of benzene, the solution is washed with 3 N hydrochloric acid and then with water. Benzene is distilled under reduced pressure, leaving cis 5- [3 (N-carbethoxy-N-methylamino)-propylidene]-10,11- diacetoxy-10,1 l-dihydro-SH-dibenzo [a,d] cycloheptene as an oily residue weighing, typically, 7.85 g. (87% EXAMPLE 15 Following the procedure of Example 14, the products enumerated below are obtained employing the 8-(3-dialkylaminopropylidene) products enumerated in Example 5 in place of cis 10,ll-diacetoxy-l0,11-dihydr-5-(3-dimethylaminopropylidene) H-dib enzo [a,d] cycloheptene.

Trans 8- 3 (N carbethoxy-N-ethylamino -propylidene] 3a, 12fi-dihydro-2,2-dimethyl-8H-dibenzo [3 ,4: 6,7] cyclohepta[ 1,2-d] -1,3-dioxole Trans 8- 3 (N-carb ethoxy-N-ethylamino) -propylidene] 3 a,l2l9-dihydro-8H-dibenzo[3,4:-6,7]cyclohepta[1,2-d1- 1,3-dioxole Trans 8- [3 (N-carbethoxy-N-methylamino) -propylidene] 3 a,12,8-dihydro-2-phenyl-8H-dibenzo[3,4: 6,7]cyclohepta[ 1,2-d] 1,3-dioxole Trans 8- [3- (N-carbethoxy-N-methylamino -propylidene] 3 a,1Zfi-dihydro-2-methyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-d]-1,3-dioxole Trans 2-b enzyl-8- 3 N-carb ethoxy-N-methylamino) propylidene1-3 01.,12 3-dil1Yd10-8H-dlb61120[3,426,7]- cyclohepta[ 1,2-d] -l,3 -dioxole Trans *8- 3- (N-carbethoxy-N-methylamino) -propylidene] 3oz, 1Zfi-dihydro-2-ethyl-2-methyl-8H-dibenzo 3,4: 6,7] cyclohepta 1,2-d] -1,3-dioxole Trans 8- [3- (N-c arbethoxy-N-methylamino -propylidene] 3 a,12B-dihydro-2,2-dimethyl-6-methylsulfonyl- 8H- dibenzo [3 ,4 6,7]cyclohepta[ 1,2-d] 1 ,3-dioxole Trans 8- [3- (N-carbethoxy-N-methylamino -propylidene] 6-Ch1OI'0-3a, 12[3-dihydro2,2-dimethyl-SH-dibenzo [3 ,4, 26,7] cyclohepta[ 1,2-d] -1 ,3,-dioxole Trans 8- [3- (N-carbethoxy-N-methylamino -propylidene] 3 a,125-dihydro-2,2-dimethyl-6-dimethylsulfamoyl-SH- dibenzo[3,4:6,7]cyclohepta[1,2-d]-l,3-dioxole 14 EXAMPLE 16 Following the procedure of Example 14, the products enumerated below are obtained employing trans 3oz,12B- dihydro 2,2-dimethyl-8-(3-dimethylamino-propylidene)- 8H-dibenzo[3,4:6,7]cyclohepta[1,2-d] 1,3 dioxole in place of cis 10,1l-diacetoxy-10,11-dihydro-5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cyclo heptene and the haloformates designated below in place of ethyl chloroformate.

Haloformate Product Benzyl chlorof0rmate trans 8-[3-(N-carbobenzoxy-N-methylamino)- propylidone]43a,12B-dihydro-2,2-dirnethyl- 8H-dibenz0[3,4:6,7]cyclohepta[1,2-d]1,3-

dioxole.

Phenyl chlorofonnate trans 8-[3-(N-earbophenoxy-N-rnethylamino) propylidene]-3a,12B-dihyd1'0-2,2-dimethyl- SLI-dibenzoBA:6,7]cyclohepta[1,2d]-1,3

dioxole.

Propyl chlorof0rmate trans 8-[3-(N-carbopropoxy-N-methylamino)- propylidene]-3a,126-dihydro-2,Z-(hmethyl- 8dLiI-di1benzo[3,4:6,7]eyclohepta[1,2-d]-1,3-

EXAMPLE 17 A solution of the oily urethane (2.8 g., 0.0076 mole) obtained in Example 14 and potassium hydroxide (2.5 g., 0.04 mole) in 25 ml. of n-butyl alcohol is stirred and heated to refluxing in a nitrogen atmosphere for 6 hours. The solvent is distilled under reduced pressure and the residue partitioned between benzene and water. After re-extraction of the aqueous phase, the combined benzene extracts are washed with water and then extracted with 15 ml. and 10 ml. portions of 0.5 M citric acid. The acid extract is rendered alkaline with sodium hydroxide and the oily base extracted into benzene. The washed and dried benzene extract is concentrated to a small volume. The product separates as a white crystalline solid and is collected, washed with benzene, and dried to obtain 1.05 g. (47% M.P. -143 C. The pure product from another experiment melts at 143l45 C. after repeated crystallizations from benzene and from mixtures of ethanol and water.

Analysis.Calcd for C H NO (percent): C, 77.26; H, 7.17; N, 4.74. Found (percent): C, 77.34; H, 7.18;

EXAMPLE 18 Following the procedure of Example 17, the products enumerated below are obtained employing the products enumerated in Examples 22 and 23 in place of the urethane used in Example 17.

Following the procedure of Example 17, the products enumerated below are obtained employing the products enumerated in Examples 15 and 16 in place of the urethane used in Example 17.

trans 10,11 dihydro-10,1l-dihdroxy-S-(3-ethylaminopropylidene -5H-dibenzo [a,d] cycloheptene trans 10,11 dihydro-10,1l-dihydroxy-S-(3-methylamin0- propylidene) -5H-dibenzo [a,d] cycloheptene trans 3-chlorol0,l1-dihydro-10,ll-dihydroxy-5-(3 -methylaminopropylidene) -5H-dibenzo[ a,d] cycloheptene trans 10,11 dihydro-10,11-dihydroxy-5-(3-methylaminopropylidene) 3 methylsul'fonyl 5H dibenzo[a,d] cycloheptene trans 10,1 l-dihydro-l0,l1-dihydroxy-3-dimethylsulfamoyl- 5 (3-methylaminopropylidene) -5H-dibenzo [a,d] cycloheptene EXAMPLE 20 Cis 10,1 l-dihydro-10,1 1-dihydroXy-5-( 3-dimethylaminopropylidene -5H-dibenzo [a,d] cycloheptene A solution of 5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene (1.06 g., 0.00386 mole) in 7 ml. of dry benzene and 0.6 ml. of dry pyridine is treated with a solution of osmium tetroxide (1.0 g., 0.00394 mole) in 6 ml. of dry benzene and the mixture allowed to stand at room temperature for 10 days. The solution is decanted from the black precipitate which separates and the solid Washed once with 25 ml. of benzene by decantation. The benzene solution and washings are filtered through diatomaceous earth. The combined precipitate and diatomaceous earth are suspended in 60 ml. of 95% ethanol and heated to refluxing for 45 minutes with 25 ml. of a saturated aqueous solution of sodium sulfite. After filtering the mixture through diatomaceous earth, the filtrate is evaporated under reduced pressure until a dark oil separates. The residue is diluted with an equal volume of water and the oily base extracted into benzene. Evaporation of the washed and dried benzene extract leaves the product as an oily solid residue weighing 450 mg. Purification by sublimation at 155 C. and 0.1 mm. and crystallization of the sublimate from a mixture of ethanol and water affords the product as a white crystalline solid, M.P. 172.5l75.5 C., in a yield of 250 mg. (20%).

Analysis.-Calcd for 'C H O N (percent): C, 77.64; H, 7.49. Found (percent): C, 77.41; H, 7.49.

I claim:

1. A compound having the formula wherein R and R are selected from the group consisting of hydrogen and lower alkyl; X and X are selected from the group consisting of hydrogen, lower alkyl, lower alkenyl, trifluoromethyl, hydroxyl, lower alkoxy, mercapto, lower alkyl sulfonyl, sulfamoyl, lower alkyl sulfamoyl and dilower alkyl sulfarnoyl; and R" and R' are selected from the group consisting of hydrogen, lower alkyl, phenyl and benzyl.

2. A compound having the formula References Cited UNITED STATES PATENTS 9/1966 Engelhardt 260--240X 2/1967 Engelhardt 260240X ALEX MAZEL, Primary Examiner J. H. TURNISPEED, Assistant Examiner U.S. 'C1. X.R.